• Users Online:210
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2021  |  Volume : 15  |  Issue : 1  |  Page : 3-11

Evaluation of Hypericum perforatum mother tincture as an antigingivitis agent in comparison with Chlorhexidine: A randomised controlled trial


1 Department of Periodontology, Haldia Institute of Dental Sciences and Research, Haldia, India
2 Department of Conservative Dentistry and Endodontics, Haldia Institute of Dental Sciences and Research, Haldia, India
3 Department of Health and Family Welfare, Government of West Bengal, Mysuru, Karnataka, India
4 Department of Periodontology, JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India

Correspondence Address:
Dr. Swet Nisha
Department of Periodontology, Haldia Institute of Dental Sciences and Research, Haldia, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijrh.ijrh_49_20

Rights and Permissions

Background: Homoeopathic medicine Hypericum perforatum (Hyper.) has antimicrobial, wound healing and anti-inflammatory activity. It has been used as an analgesic postextraction, for nerve pain, burning mouth syndrome singly, or in combination with other Homoeopathy medications. Objective: Evaluation of the efficacy of Hyper. Q in reducing dental plaque and gingival inflammation. Materials and Methods: Three hundred and eighteen participants with chronic gingivitis (probing depth ≤ 3 mm) and bleeding gums were recruited and allocated randomly into three groups (n = 106 each): Group A (saline mouthwash), Group B (Hyper.) and Group C (Chlorhexidine [CHX]). Clinical parameters: Plaque index (PI), gingival index (GI), sulcus bleeding index (SBI) and oral hygiene index simplified (OHIS) were measured at baseline, first, third and sixth month. Results: All the three groups showed a statistically significant reduction in the PI, GI, SBI and OHIS (P < 0.05) at 3 months. Intergroup comparison showed significant reduction in PI, GI, SBI and OHIS (P < 0.05) in Group C compared to Groups A and B. Group B showed a statistically significant reduction in all clinical parameters when compared to Group A (P < 0.05) after 3 months. At 6 months, all the groups showed statistically significant reduction (P < 0.05) in all the clinical parameters; however, intergroup comparison did not show significant difference (P > 0.05). Conclusion: The present study demonstrated that the use of Hyper. Q as mouthwash significantly reduces plaque and gingival inflammation as compared to saline as mouthwash. However, CHX was found better than Hyper. Future research on use of Hyper. Q, dosage, substantiality and antimicrobial properties is warranted for its potential clinical use.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed574    
    Printed4    
    Emailed0    
    PDF Downloaded189    
    Comments [Add]    

Recommend this journal